Study S001195

A Randomised, Double-blinded, Cross-over Study Investigating the Short-term Impact of Liraglutide on Kidney Function in Diabetic Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01664676
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: COMPLETED
Enrollment: 11
Start: 2012-12
Primary completion: 2014-02
Lead sponsor: University of Aarhus
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:Liraglutide; DRUG:Placebo-liraglutide
Results posted: FALSE
Secondary identifiers: EUDRACT_NUMBER:2012-003577-26

Registered primary outcomes

Glomerular Filtration Rate (51Cr-EDTA plasma clearance) [10-15 hours post-dose]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.